Can talking about diabetes feelings improve blood sugar?
NCT ID NCT04016558
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested three different programs to help adults with type 1 diabetes manage the stress and worry that often comes with the condition. 296 participants were split into groups, each trying a different approach: one focused on emotional awareness, another on problem-solving, and a third on education and blood sugar management. The goal was to see if these programs could reduce diabetes distress and improve blood sugar control over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral programs (TunedIn, FixIt, StreamLine)
- What this could lead to
- If successful, these programs could offer practical ways to reduce the emotional burden of managing type 1 diabetes and improve blood sugar levels.
- What could go wrong
- This is a completed behavioral study, so results are available but may not apply to everyone. The programs require time and effort, and benefits may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
296 people
The number who actually took part.
- Started
-
Sep 2019
- Finished
-
Feb 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients with type 1 diabetes (confirmed by clinical history and/or anti-glutamic acid decarboxylase\] antibody testing) on intensive insulin treatment; * Diagnosis of type 1 diabetes for at least 12 months that occurred at or below age 40; * Have a recent HbA1c of 7.5% or higher; * Not have started to use any new (to the participant) diabetes device (such as an insulin pump or continuous glucose monitor) in the past 6 months; * Internet access through a computer or smart phone; * Ability to speak/read English. Exclusion Criteria: * No documented psychosis, blindness, dementia, active dialysis, substance abuse, amputations, or severe functional deficits, or recent major surgery or hospitalization in the past year.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes distress are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Can a math model tune insulin pumps better than standard care?
- Can a group program stop eating disorders in type 1 diabetes?
- Can a glucose app that predicts lows calm diabetes fears?
- Can a Two-Punch immune therapy save insulin cells in newly diagnosed diabetes?
- Can a smart insulin pump tailored for pregnancy protect mothers and babies?